Biofrontera, Inc. (NASDAQ:BFRI) Q1 2022 Results Conference Call May 13, 2022 11:00 AM ET

Company Participants

Tirth Patel - LHA IR

Hermann Lubbert - Executive Chairman

Erica Monaco - CEO

Operator

Good morning and welcome to the Biofrontera Inc’s First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Tirth Patel with LHA Investor Relations. Please go ahead, sir.

Tirth Patel

Good morning, and welcome to Biofrontera Inc.'s first quarter 2022 financial results conference call. Please note that certain information discussed during today's call is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that Biofrontera's management will be making forward-looking statements and that actual results may differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. All risks and uncertainties are detailed in and are qualified by the cautionary statements contained in Biofrontera's press releases and SEC filings.

Also this conference call contains time-sensitive information that is accurate only as of the date of the live broadcast, today, May 13, 2022. Biofrontera undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date

of this conference call, except as required by law.

During today’s call there will also be references to certain non-GAAP financial measures. Biofrontera believes these measures provide useful information for investors, yet should not be considered as a substitute for GAAP, nor should they be viewed as a substitute for operating results determined in accordance with GAAP. A reconciliation of non-GAAP to GAAP results is included in this morning’s press release. More specifically management will be referencing EBITDA, a non-GAAP financial measure defined as net income or loss excluding interest income and expense, income taxes, depreciation and amortization, legal settlement expense and certain other non-recurring or noncash items.

With that, I would like to turn the call over to Hermann Lubbert, Executive Chairman of Biofrontera Inc.

Hermann Lubbert

Thank you, Tirth. Welcome, everyone to Biofrontera Inc.'s first quarter 2022 financial results conference call. Joining me today is Erica Monaco, our Chief Executive Officer. In a moment, Erica will review the business, our strategy and our recent financial results. But first, I would like to say a few words.